The stem cell leukaemia (SCL) gene is a member of the basic helix-loop-helix family of transcription factors and is essential for the development of all haematopoietic lineages. SCL is expressed in pluripotent haematopoietic stem cells and also following commitment to the erythroid, mast and megakaryocytic lineages. The mechanisms responsible for this pattern of expression are poorly understood, but are likely to illuminate the molecular basis for stem cell development and lineage commitment. Here we present the first description of the regulation of the SCL gene in mast cells. In this study we systematically analysed the chromatin structure of a 45 kb region of the murine SCL locus in mast cells. The pattern of DNase 1 and restriction endonuclease hypersensitive sites in mast cells was distinct from, but overlapped with, the pattern previously described in erythroid and primitive myeloid cells. Each potential regulatory element was tested using transient reporter assays to assess their functional significance in mast cells. These studies identified two potent enhancers, one of which was downstream of the SCL gene. Further characterisation of this 3Ј enhancer demonstrated that it required the presence of two distinct DNase 1 hypersensitive sites for full activity, and that it was capable of stimulating transcription from both promoter 1a and 1b. Since the 3Ј enhancer is active in both erythroid and mast cells, it will now be important to see whether it is independently activated in these lineages, or whether it is also active in haematopoietic stem cells.
Introduction
A central question in haematopoietic development concerns the mechanisms whereby a pluripotent stem cell reproducibly generates multiple distinct differentiated cell types. The complexity of lineage commitment involves a highly controlled developmental progression through successive stages of differentiation. It is clear that these processes are regulated in part by key transcription factors. As a consequence, it is of particular importance to identify such regulators and understand how they themselves are controlled -what regulates the regulators? To address these questions we have chosen to study the stem cell leukaemia (SCL) gene, which encodes a basic helix-loop-helix (bHLH) transcription factor, is expressed in pluripotent haematopoietic stem cells and functions as a pivotal regulator of haematopoiesis.
The SCL gene (also known as TAL-1) was originally identified as a result of its activation by chromosome rearrangements affecting chromosomal band 1p32, which is where the gene is located, in T cell acute lymphoblastic leukaemia (T-ALL). [1] [2] [3] [4] Genomic rearrangements of the SCL gene have been reported in approximately 30% of patients with paediatric T-ALL 5, 6 and it has been suggested that additional mechanisms may be responsible for ectopic expression in a further 30% of these patients. 4 Transgenic studies in mice have also shown
Correspondence: AR Green; Fax: 44 01223 336827 Received 4 September 1998; accepted 20 February 1999 that ectopic expression of SCL in thymocytes gives rise to T cell tumours. [7] [8] [9] [10] The murine SCL gene has 7 exons spanning 15 kb of DNA. Two promoters are present in alternate 5Ј exons and exhibit lineage-restricted activity in different haematopoietic cell types. [11] [12] [13] A third promoter in exon 4 has also been reported in the human SCL gene.
14 SCL expression is normally restricted to haematopoietic tissues, endothelial cells, the heart and distinct regions in the brain. [15] [16] [17] Within the haematopoietic system SCL is expressed in committed erythroid, mast and megakaryocytic cells as well as in primitive myeloid cells and multipotent progenitors. 15 -20 SCL appears to perform different functions within distinct haematopoietic lineages. Expression of antisense SCL constructs in a multipotent cell line resulted in reduced proliferation and self-renewal 21 whereas the results of similar experiments showed an inhibition in erythroid differentiation of a committed erythroid cell line. 22 Overexpression of exogenous SCL impaired macrophage differentiation of M1 cells suggesting that down-regulation of SCL expression may not only accompany but also be essential for normal myeloid differentiation. 23 Growth factor-induced erythroid differentiation of a multipotent progenitor cell line was accompanied by up-regulation of SCL mRNA, whereas induced granulocyte/monocyte differentiation resulted in extinction of SCL expression. 24 Similarly, constitutive overexpression of normal, mutant or truncated SCL polypeptides in myeloid progenitor cell lines suggested that SCL modulates several physiological processes including proliferation, differentiation and apoptosis. 25 Knockout studies have demonstrated a critical role for SCL in haematopoietic stem cell formation or function. Mice lacking SCL protein died at 9.5 days post-coitus and exhibited a complete absence of all haematopoietic cells. 26, 27 In addition, SCL null ES cells failed to give rise to haematopoietic colonyforming cells in vitro and also did not contribute to haematopoietic tissues in vivo. 28, 29 Recent zebrafish experiments suggest that SCL acts at an even earlier stage, since ectopic SCL expression specified haemangioblast development from early mesoderm at the expense of other mesodermal cell fates. 30 The concept that SCL plays an important role in vasculogenesis is consistent with recent reports that SCL is required for normal yolk sac formation 31 and that SCL can partially rescue both vascular and haematopoietic defects in the zebrafish mutant, cloche.
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The complex pattern of SCL expression raises important questions about the molecular mechanisms underlying lineage-restricted SCL expression in different cell types. We have therefore identified a number of regulatory elements responsible for lineage-specific expression of the murine SCL gene in erythroid and CD34 + myeloid cells. 33 However, nothing is known about SCL enhancers directing expression to mast cells. Mast cells play a central role in host responses to both allergens and parasites 34, 35 but relatively little is known about the transcriptional programs of mast cells and only a few mast cell-specific elements have been reported. [36] [37] [38] [39] [40] [41] [42] In this paper we have therefore identified and mapped DNase 1 hypersensitive sites within a 45 kb region of the murine SCL locus in mast cells. Transient reporter assays have been used to assign functional activity to these elements. Two exhibited potent enhancer activity in mast cells. Further characterisation of one of these (the 3Ј enhancer) demonstrated that it required the presence of two distinct DNase 1 hypersensitive sites for full activity and that it was capable of stimulating transcription from both SCL promoter 1a and 1b within mast cells.
Materials and methods

Cell lines
The factor-independent murine mast cell lines 6− and MST96.47B3 have both been previously described. 13 
Analysis of DNase 1 hypersensitivity
Approximately 3 × 10 8 cells were rinsed in phosphate-buffered saline (PBS) and resuspended in 20 ml of homogenisation buffer (10 mM Tris pH 7.4, 15 mM NaCl, 0.15 mM spermine, 0.5 mM spermidine, 1 mM EDTA, 0.1 mM EGTA, 0.2% NP-40, 5% sucrose). After Dounce homogenisation, the homogenate was spun through a 10% sucrose layer and resuspended in buffer (10 mM Tris pH 7.4, 15 mM NaCl, 60 mM KC1, 0.15 mM spermine, 0.5 mM spermidine). After adding DNase 1 (Sigma, Poole, UK) (0.8-16 g), samples were incubated at 37°C in the presence of 50 mM MgCl 2 and 50 mM CaCl 2 for 10 min. Reactions were stopped by adding 12.5 mM EDTA and 1% SDS and the DNA was isolated following proteinase K digestion/phenol extraction and ethanol precipitation. After digestion with restriction enzymes, the DNA was analysed by Southern blotting. Probes used were as follows: fragment p2 -a 220 bp Sau3AI/ApaI fragment 50 bp upstream of exon la; p3-900 bp SmaI/SacI fragment, p4-180 bp SacI/SmaI fragment, p5 -a 1200 bp HindIII fragment 260 bp upstream of the EcoRI site in exon VI; p6 -an 400 bp SacI/ScaI fragment extending 3Ј of SCL exon VI.
Restriction endonuclease accessibility assay
The method for the restriction endonuclease accessibility assay was kindly provided by Prof Doug Higgs (Institute of Molecular Medicine, Oxford). Approximately 1 × 10 8 cells were spun down and washed twice with PBS. The pellet was resuspended in 4 ml of high salt lysis buffer (50 mM KCl, 10 mM MgSO 4 , 3 mM DTT, 5 mM HEPES, 0.05% NP40) and the cells left for 1 h at room temperature. Nuclei were pelleted by spinning at 1000 g for 5 min. The nuclei were washed in RSB buffer (10 mM NaCl, 10 mM Tris/HCl pH 7.4, 3 mM MgCl 2 6H 2 O) repelleted and divided into aliquots of approximately 1 × 10 7 cells. 0-400 units of restriction enzyme were then incubated with the nuclei aliquots at 37°C for 1 h. The incubation was stopped by the addition of tail buffer (50 mM Tris/HCl pH 7.4, 100 mM EDTA, 100 mM NaCl, 1% SDS) to the aliquots and incubated with proteinase K (1 mg/ml) at 55°C for 2.5 h. The DNA was isolated following proteinase K digestion/phenol extraction and ethanol precipitation. The probes used were the same as for DNase 1 hypersensitive site analysis ( Figure 1 ) except for the probe; p1 -170 bp KpnI/SpeI.
Preparation of reporter constructs
Luciferase reporter constructs were generated in pGL-2 basic as previously described. 33 The +0.2E2b construct was generated by cloning an approximately 1 kb Vent polymerase (New England Biolabs, Beverly, MA, USA) PCR fragment containing promoter lb and exon IIb into the SmaI site (maintains the SmaI site) between promoter 1a and 1b and an XhoI within the previously described −0.2E3. 33 The PCR construct was subsequently sequenced.
Transient transfections
Transient transfections were carried out as described 11 with the exception that only 5 g of the pEF-BOS lacZ vector was used for normalisation of each pulse. Also, in order to adjust for the large size differences between the reporter constructs used in this study, the molar amount of reporter construct added to each pulse was kept constant using 5 g of pGL-2 basic and proportionally more of the larger constructs. The total amount of DNA added to each pulse was kept constant by adding the required amount of the plasmid pks-bluescript (Stratagene, La Jolla, CA, USA). Luciferase and ␤-galactosidase assays were carried out as described. 11 The relative light units presented are the mean of at least four independent experiments and the results obtained were confirmed using a second DNA preparation for each construct.
Results
Mast cells possess a distinct lineage-restricted pattern of DNase 1 hypersensitive sites
Lineage-specific expression of the SCL promoter has been studied in erythroid, early myeloid and T cells lines. 11, 12, 44 However, nothing is known about the molecular mechanisms underlying lineage-restricted expression of SCL in mast cells. We therefore elected to study two well characterised murine mast cell lines, Mst 96.47B3 and 6−, which express the mast cell-specific Fc⑀ receptor I, GATA-1, GATA-2 and comparable levels of SCL. 13 DNase 1 hypersensitive site analysis was used to identify putative regulatory elements in a region of 45 kb spanning the murine SCL locus. Figure 1a is a schematic representation of the strategy used to analyse the SCL locus. Probe p2 was used to identify hypersensitive sites 5Ј of the promoter region. As shown in Figure  1b , probe p2 was hybridised to a filter containing DNase 1-treated DNA subsequently digested with the ApaI restriction enzyme. In addition to the germline fragment of approximately 23 kb (closed arrowhead), two additional bands were also observed at approximately −9 kb and −4 kb (open arrowheads). All the numbering of the hypersensitive sites refers to their position relative to the beginning of exon la.
To identify DNase 1 hypersensitive sites within the body of the SCL gene, DNase 1-treated DNA was digested with either To confirm the reproducibility of this pattern of DNase 1 hypersensitive sites we analysed a second mast cell line, 6−, using a restriction endonuclease accessibility assay. 45 The technique is essentially similar to DNase 1 hypersensitive site analysis with the exception that isolated nuclei were incubated with a restriction enzyme instead of DNase 1. We have found this technique to be faster and less technically demanding than DNase 1 hypersensitive site analysis. In addition, the use of several 'frequent-cutter' restriction endonucleases permits the precise mapping of the DNase 1 hypersensitive sites if the sequence of the region is known. Figure 2a is a schematic representation of the restriction digestions and DNA probes used to analyse the SCL locus in 6− cells. In Figure 2b isolated nuclei were incubated with AvaII and the DNA subsequently isolated and digested with KpnI. The DNA was then Southern blotted and the filter hybridised with probe p1. In addition to the germline fragment of 6.7 kb (closed arrowhead), a 1.5 kb band (open arrowhead) was also observed corresponding to a hypersensitive site 8.6 kb upstream of exon 1a (−8.6HS) (Figure 2b ). In Figure 2c nuclei were digested with RsaI, the DNA subsequently digested with KpnI and run on the same gel as in Figure 2b . Southern blot filters were hybridised with probe p1. The expected germline fragment of 6.7 kb was observed (closed arrowhead) with a faint but reproducible band at approximately 1 kb representing a hypersensitive site 8.1 kb upstream of promoter 1a (−8.1HS). The band at approximately 3 kb seen in all lanes in Figures 2b and 2c is likely to represent crosshybridisation or a KpnI polymorphism within the SCL locus.
There are 14 AvaII and 20 RsaI recognition sites spread throughout the 6.7 kb KpnI fragment (data not shown), illustrating that the bands we observe represent specific hypersensitive sites. In addition, there are AvaII recognition sites between the −8.6HS and the 8.1HS which do not cut, suggesting the existence of two distinct hypersensitive sites rather than a single one.
In Figure 2d nuclei were incubated with MspI, the DNA isolated and then digested with ApaI. The DNA was Southern blotted and the filter hybridised with probe p2. A 23 kb germline band was observed in the control lane but was very sensitive to MspI digestion. A 4 kb fragment represented the −4HS (open arrowhead). The band at approximately 5 kb was observed irrespective of the initial restriction enzyme used and probably represents cross-hybridisation.
To confirm the DNase 1 hypersensitive sites identified within the 5Ј portion of the body of the SCL gene, DNA was extracted from HhaI or Sau96A-treated nuclei, subsequently digested with SacI and hybridised with either probe p3 or p4. In Figure 2e a 5 kb germline band was accompanied by three smaller bands of 2 kb, 1.7 kb and 1 kb representing hypersensitive sites over promoter 1a, promoter 1b and a hypersensitive site 1 kb downstream of promoter 1a (+1HS). In Figure 2f two additional bands could be seen (open arrowheads) corresponding to hypersensitive sites at promoter 1a (2 kb band) and the +0.7HS (1.3 kb band). There are no Sau96A sites within promoter 1b or the +1HS which explains why there are no bands corresponding to these sites detected. However, the sequence of this region demonstrates the existence of Sau96A and HhaI sites between +0.7HS and +1HS which remain uncut thus demonstrating the existence of two spatially distinct regions of hypersensitive chromatin (data not shown). In addition, appropriately digested DNA samples representing the +1HS and +0.7HS have been run on the same gel and show clear differences in migration (data not shown).
In Figure 2 g a filter containing HhaI + SacI-digested DNA was hybridised with probe p4 to yield a 1.1 kb germline band and a 0.5 kb band corresponding to the +3HS. In order to survey the 3Ј portion of the body of the SCL gene, nuclei were incubated with HhaI, DNA subsequently digested with EcoRI and hybridised with probe p5 (Figure 2h) . A 10 kb germline band was seen together with an 8 kb band representing the +7HS.
Finally, to confirm the DNase 1 hypersensitive sites identified downstream of the SCL gene, DNA from ScrFI or HaeIIItreated nuclei was digested with SacI, and Southern filters hybridised with probe p6. In addition to the 5 kb germline fragment, bands at approximately 1.2 kb (Figure 2i , open arrowhead) and 2.3 kb (Figure 2j , open arrowhead) were also evident corresponding to the +17HS and +18HS, respectively. The additional faint bands observed in Figure 2i are likely to reflect 'background cutting' due to digestion of DNA from lysed nuclei during the incubation step at 37°C and were not reproducible.
A summary of the nuclease hypersensitive sites is depicted schematically in Figure 3 . Importantly, we consistently observed the same pattern using the different techniques in two independently generated mast cell lines. Furthermore, the pattern overlaps with but is distinct from that previously seen in erythroid and primitive myeloid cell lines. 33 
Lineage-restricted regulatory elements modulate SCL transcription in mast cells
To investigate the function of the putative SCL regulatory elements in mast cells we have used a panel of luciferase reporter constructs and assessed their activity following transient transfection into Mst cells. Initial studies focused on the regions surrounding promoter 1a and promoter 1b. Both core promoter 1b (construct +0.2E1b) and promoter 1a (construct −0.2E1a) were active in Mst cells, consistent with previous findings 13 ( Figure 4 ). By contrast, transient reporter assays revealed activity of only promoter 1a in erythroid cells, and only 1b in primitive myeloid cells. 12 However, a construct containing both promoters with the luciferase gene fused into exon 3 (−0.2E3), and which therefore contained the +0.7HS, +1HS and +3HS, was approximately 10-fold more active than either of the promoters alone. This effect may reflect altered RNA processing and/or stability resulting from the inclusion of introns in the −0.2E3 construct, although this seems unlikely because the parental pGL-2 basic vector already includes an intron. Interestingly, removal of the +3HS (construct −0.2E2b) reduced activity to the level of the 1b promoter alone (Figure 4) . The activity of the −0.2E2b construct is also comparable to a construct containing just promoter 1a and 1b. 13 These results suggest that the region containing the +3HS acts as a potent enhancer.
The SCL gene exhibits complex alternate splicing patterns involving the 5Ј untranslated exons and which results in exon 3 being the first exon that is shared between transcripts originating at either promoters 1a or promoter 1b. Since distant regulatory elements may potentially act on promoter 1a, promoter 1b or both, we tested the effects of DNA fragments containing the various hypersensitive sites on the activity of the −0.2E3 cassette. DNA fragments containing the −8.6/−8.1HS, +7HS, and +17/+18HS were subcloned downstream of the luciferase gene in −0.2E3. The −4HS was tested by including 7 kb of sequence upstream of exon 1a (construct −7.0E3). Transient luciferase reporter assays were then performed in Mst cells to assess the effect of all these hypersensitive sites on the activity of −0.2E3 ( Figure 5 ).
Figure 5
Transient transfection analysis of hypersensitive site function. Transient transfections were performed using Mst cells. The constructs and the additional hypersensitive sites (HS) that are not present within the −0.2E3 cassette are indicated on the left. Fold activation values represent luciferase activity (normalised against ␤-gal values) relative to luciferase activity obtained using −0.2E3.
Luciferase activities are presented relative to the −0.2E3 construct which is already 450-fold more active than pGL-2 basic. The addition of either the −8.6/−8.1HS, or −4HS had little or no effect on luciferase activity. Addition of the +7HS resulted in an approximately two-fold drop in activity which may represent a modest silencing effect. By contrast, the addition of +17/+18HS resulted in a 3.5-fold increase in luciferase activity over −0.2E3 and a 1350-fold increase relative to pGL2 basic. The activity of the +17/+18 HS is lineage restricted since this construct exhibited no activity in a T cell (non-SCL expressing) or primitive myeloid cell line. 33 
Both the +17HS and +18HS are required for full activity of the 3Ј enhancer in mast cells
Since the 3Ј enhancer contains two hypersensitive sites it was important to assess whether the +17HS, the +18HS or both were responsible for the enhancer activity in mast cells. A series of constructs was therefore generated to map more precisely the enhancer element. The constructs are illustrated in Figure 6a . Three constructs were generated, a 3 kb HindIII fragment which contains both the +17HS and +18HS (−0.2E3/a), a BglII/BamHI fragment containing the +17HS (−0.2E3/b), and a BamHI/SacI fragment containing the +18HS (−0.2E3/c). The activity of the constructs was measured following transient transfection into Mst cells (Figure 6b) . The −0.2E3/+17,18 and −0.2E3/a constructs both exhibited approximately 3.5-fold greater activity than −0.2E3 alone. Interestingly, the +17HS alone (−0.2E3/b) displayed no enhancing activity and the +18HS alone (−0.2E3/c) gave rise to only a two-fold stimulation relative to −0.2E3. These data demonstrate that both the +17HS and the +18HS were required for full activity of the 3Ј enhancer.
The 3Ј enhancer activates both promoter 1a and promoter 1b
The −0.2E3 cassette contained both promoter 1a and promoter 1b, and so the 3Ј enhancer might potentially interact with one or both SCL promoters. In order to address promoter specificity of the 3Ј enhancer we took advantage of a further The +17HS and +18HS element function co-operatively. series of constructs containing promoter 1a, promoter 1b, or the SV40 early promoter in pGL2 with the +17/+18HS element cloned downstream of the luciferase gene. 33 The constructs were transiently transfected into Mst cells and their activities measured by luciferase reporter assays (Figure 7) . Interestingly, the +17/+18HS was able to enhance approximately three-fold transcription from both promoter 1a and promoter 1b and also produced a four-fold increase in transcription from the SV40 promoter. Thus, in a mast cell environment, but not in an erythroid environment 33 the 3Ј enhancer was capable of acting on both promoter 1a and promoter 1b.
Discussion
SCL is expressed in multipotent progenitors and also in committed erythroid, mast and megakaryocytic cells [15] [16] [17] 24 but SCL expression is extinguished during differentiation along other lineages. 23, 24 This expression pattern suggested that SCL might play an important role in haematopoiesis, a concept that was confirmed by the generation of SCL null mice which failed to develop all haematopoietic lineages. 28, 29 We have elected to dissect the mechanisms which control SCL expression throughout haematopoiesis in order to illuminate the molecular basis for stem cell development and lineage commitment.
Mast cells are crucial for protective responses to parasitic infections and are also the major cellular mediator for many allergic reactions. Identification of SCL enhancers that target mast cell progenitors and mature mast cells will shed light on the mechanisms responsible for maintaining SCL expression following lineage commitment. Such enhancers would also allow targeted expression of exogenous genes within the mast cell lineage, and would therefore provide powerful tools for experimental and therapeutic manipulation of mast cells. We have previously characterised the molecular basis for the activity of SCL promoter 1a and promoter 1b in mast cells. 13 However, nothing is known about distant SCL regulatory elements in mast cells.
In this paper we have undertaken a systematic analysis of DNase 1 hypersensitive sites within a region of approximately 45 kb spanning the SCL gene. This has allowed us to compare the pattern of DNase 1 hypersensitive sites in mast cells with the patterns we have previously observed in two other haematopoietic lineages, namely erythroid and primitive myeloid cells. 33 Furthermore, we have now used restriction endonuclease accessibility to provide high resolution mapping of the precise location of the regions of open chromatin in mast cells.
Our results have identified two hypersensitive sites (+0.7HS and +1HS) previously unrecognised in other SCL-expressing cell types. Given the relatively low resolution of DNase 1 hypersensitive site studies, it will be important to assess whether these two sites are in fact present in other SCLexpressing lineages, or whether they are indeed mast cell restricted. It is also interesting to note that the intron between exons 1b and 2b which contains the +0.7HS and +1HS, also contains a 400 bp stretch of sequence that is well conserved between man and mouse (data not shown).
The −10HS described previously 33 was also mapped using DNase 1 hypersensitive site analysis with a relatively low resolution. Here, we have used restriction endonuclease accessibility to precisely map a doublet of hypersensitive sites at −8.6/−8.1 kb. In addition, we have now confirmed that in erythroid cells the '−10HS' also consists of two regions of open chromatin 8.6 and 8.1 kb upstream of promoter 1a (data not shown).
The results presented here demonstrate the presence of a consistent pattern of hypersensitive sites in mast cells, which overlaps with but was distinct from the patterns previously described in erythroid and primitive myeloid cells. In particular, the −8.6HS, −8.1HS and +7HS were present in mast, erythroid and primitive myeloid cells. By contrast, the +3HS, +17HS and +18HS were found in mast and erythroid and the −4HS was found in mast and primitive myeloid cells. A second hypersensitive site observed 3 kb upstream of promoter 1a (−3HS) in primitive myeloid cells is not present in mast cells. The significance of these distinct patterns of hypersensitive sites in different lineages is not clear, but suggests that distinct combinations of regulatory elements may be responsible for modulating SCL expression in different haematopoietic cell types.
Functional assays of the various hypersensitive sites identified two regions with particularly powerful enhancer activity in mast cells. The first of these was a region containing the +3HS in the body of the SCL gene. This region functioned in a similar manner in both erythroid and primitive myeloid cells. 33 Interestingly, the human SCL gene contains a hypersensitive site at approximately the same position 46 and comparison of the human and mouse sequence has revealed a highly conserved stretch of 150 bp immediately upstream of exon 3. 47 These data therefore suggest the presence of a conserved intronic enhancer which functions in multiple haematopoietic lineages.
The second potent enhancer was downstream of the SCL gene. The position of this 3Ј enhancer was marked by two hypersensitive sites, +17HS and +18HS. DNA fragments containing both hypersensitive sites were required for full enhancer activity. We have previously shown that a the 3Ј enhancer upregulates the −0.2E3 promoter cassette in erythroid cells but not in T cells or primitive myeloid cells. 33 Furthermore the +17 and +18 DNase 1 hypersensitive sites were not detectable in primitive myeloid cells or T cells. 33 These data strongly suggest that the enhancer exhibits celltype specificity. Within a given cell type, we speculate that the promoter specificity of the enhancer may depend on whether the promoters being tested are potentially active and therefore permissive for enhancer function. Thus, both promoter 1a and 1b are active in mast cells (and therefore able to respond to the enhancer), whereas the core promoter 1b is inactive in erythroid cells (and therefore not responsive to the enhancer). These data therefore raise the possibility that lineage-restricted transcription factors needed for promoter activity may also be required for promoter/enhancer interaction. Promoter 1a and 1b contain Sp1 sites and promoter 1a contains two GATA sites. It may therefore be relevant that both GATA-1 and Sp1 have been shown to participate in protein-protein interactions which may mediate the physical association of promoters with enhancers. [48] [49] [50] The data presented here together with our previous studies show that the 3Ј enhancer is active in mast and erythroid cells but is inactive in primitive myeloid cells and T cells. 33 However, the SCL gene itself is expressed in haematopoietic stem cells and its expression is subsequently maintained following commitment to erythroid, mast and megakaryocytic lineages but down-regulated following commitment to myeloid and lymphoid lineages. 51 It will now be important to address whether the 3Ј enhancer is activated independently in the mast and erythroid lineages or whether it is also active in haematopoietic stem cells.
